Alzheimer disease is a brain disease that brings gradual degradation of memory, and results in dementia
after severe intelligence loss as to not be able to continue everyday life. Alzheimer Dementia consists of
75% of all dementia and there are 36 million patients worldwide.¹ In most cases Alzeheimer induced
Dementia occurs around 65 years of age, but in rare cases, may happen before that.
Alzheimer’s Disease has a very high inheritance rate. Even in the cases of late-onset, the inheritance rate is
60~80%.² For example, APOE is a gene that allows for the certainty, and can be used to explain 20% of all
Alzheimer diseases.³ But not everyone contracts Alzheimer disease due to family history, as there are
environmental factors such as eating habits, and life style choices.
is a DNA chip based diagnostics test that analyzes DNA extracted from blood to
estimate the risk of contracting Alzheimer’s disease.
We have made a predictive model from the well-documented and frequent genes associated with Alzheimer
and tested on Korean population to do a retrospective risk prediction and classification of high-risk group.
There isn’t any method of complete treatment but there exists a symptom-alleviating treatment.⁴and
therefore, prevention is absolutely needed. screens high-risk group to allow for healthier
old age through prevention and management.
is a prediction test for Alzheimer induced risk. 3 out of 4 dementia
patients with age 65 or more is from Alzeheimer’s Disease and the number is increasing.
SD Genomics performs genetic tests to the requests of medical institutes following the Bioethics and Safety Act. Prior to service request,
understanding the objective of the test, reporting method of the test, and limitations of the test is necessary.
|Required Documents||Test Requirement and Consent form (provided below)|
|TAT||Within 4-6 weeks|